Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Sprouty-2 via down regualtion of its target gene, 7/April/2014, 9.38 am

Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Sprouty-2 via down regualtion of its target gene, 7/April/2014, 9.38 am

Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Sprouty-2 via down regualtion of its target gene, 7/April/2014, 9.38 am 150 150

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor Sprouty-2 via  down regualtion of  its target gene, 7/April/2014, 9.38 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing